30
11/21
NEWS
World Prematurity Day: Chiesi’s commitment for the...
At Chiesi we are committed to saving the life of the premature babies and to improving the quality of their...
  • PRESS RELEASE
    Chiesi and UCB enter global license agreement for...
    UCB has granted to Chiesi global exclusive rights to develop, manufacture, and commercialise zampilimab, a monoclonal antibody...